High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure.
Gokel
Y
Y
Paydas
S
S
Duru
M
M
D058186:Acute Kidney Injury / Q000209:etiology* / Q000378:metabolism; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications* / Q000503:physiopathology; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects*
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D007211:Indoles; C052035:trandolapril; D014700:Verapamil; D003402:Creatine Kinase